Influence of Venous Access Site and Right Atrial Anatomical Variants on the Detection of Patent Foramen Ovale During Agitated Saline Contrast Transesophageal Echocardiography
Echocardiography · 2026
DOI: 10.1111/echo.70401 ↗At a glance
Journal article in Echocardiography, 2026. Written by Damla Raimoglou and 11 co-authors. Institution: Department of Cardiology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey. Major MEDLINE topics: Echocardiography, Transesophageal, Foramen Ovale, Patent, Contrast Media, Saline Solution. 13 references.
Abstract (original language)
Background
Contrast‐enhanced transesophageal echocardiography (cTEE) is the gold standard for the detection of patent foramen ovale (PFO). However, the diagnostic yield may vary depending on the venous injection site of the saline contrast medium and the presence of anatomical variants such as the Eustachian valve (EV) or Chiari network (CN), which can alter right atrial flow dynamics. This study aims to evaluate whether the route of injection—an upper‐extremity vein vs. a lower‐extremity vein—affects PFO detection and whether the presence of EV or CN further influences shunt visualization.
Methods
We prospectively enrolled 174 patients referred for cTEE for suspected cardioembolic etiology. Agitated saline contrast was injected via an upper‐extremity vein (brachial/antecubital vein; UEV) and via a lower‐extremity vein (saphenous veins; LEV) during standardized Valsalva maneuver. Each route was tested with up to three adequately performed injections irrespective of the alternate‐route result. PFO was defined as microbubbles visualized traversing the interatrial septum within the first five cardiac cycles after right atrial opacification and Valsalva release. EV/CN was recorded. EV length and mobility and atrial septal aneurysm (ASA) were assessed by re‐review of archived TEE images.
Results
PFO was detected in 73/174 (42.0%) by either route. UEV was positive in 58/174 (33.3%) and LEV in 64/174 (36.8%) ( p = 0.307). Among PFO‐positive patients, 49 (67.1%) were positive with both routes, 9 (12.3%) only with UEV injection, and 15 (20.5%) only with LEV injection. EV was present in 56/174 (32.2%) and CN in 4/174 (2.3%); among PFO‐positive patients, EV was present in 31/73 (42.5%) and CN in 2/73 (2.7%). In EV‐positive PFO patients (n = 31), positive LEV injection detected 31/31 (100%) whereas positive UEV injection detected 17/31 (54.8%) ( p = 0.000122). LEV‐only positivity occurred in 9/11 patients with EV length ≥10 mm versus 5/20 with EV length
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
- Department of Cardiology, SUNY Downstate Medical Center, Brooklyn, USA.
- Department of Cardiology, Yedikule Surp Pırgic Armenian Hospital, Istanbul, Turkey.
- Department of Cardiology, Koc University, Istanbul, Turkey.
ORCID profiles: Damla Raimoglou
Cite
APA
Raimoglou, D., Mutlu, D., Karadag, B., Ikitimur, B., Çeviker, A., Ozal, A., Dogramaci, E., Aygun, A. A., Raimoglu, U., Tokdil, K. O., Tokdil, H., & Durmaz, E. (2026). Influence of Venous Access Site and Right Atrial Anatomical Variants on the Detection of Patent Foramen Ovale During Agitated Saline Contrast Transesophageal Echocardiography. Echocardiography. https://doi.org/10.1111/echo.70401
Vancouver
Raimoglou D, Mutlu D, Karadag B, Ikitimur B, Çeviker A, Ozal A, et al. Influence of Venous Access Site and Right Atrial Anatomical Variants on the Detection of Patent Foramen Ovale During Agitated Saline Contrast Transesophageal Echocardiography. Echocardiography. 2026. doi:10.1111/echo.70401
BibTeX
@article{Raimoglou2026,
author = {Raimoglou, Damla and Mutlu, Deniz and Karadag, Bilgehan and Ikitimur, Baris and Çeviker, Arda and Ozal, Ayten and Dogramaci, Efekan and Aygun, A Atıl and Raimoglu, Utku and Tokdil, Kardelen Ohtaroglu and Tokdil, Hasan and Durmaz, Eser},
title = {Influence of Venous Access Site and Right Atrial Anatomical Variants on the Detection of Patent Foramen Ovale During Agitated Saline Contrast Transesophageal Echocardiography},
journal = {Echocardiography},
year = {2026},
doi = {10.1111/echo.70401}
}
EUVIMED